Crown Laboratories Acquires Rights for GSK’s Five OTC Drugs
Crown Laboratories Acquires Rights for GSK’s Five OTC Drugs
- Crown to get North American rights of GSK’s OTC drugs namely, PanOxyl, Sarna, Zeasorb, Desenex, Mineral Ice
- The focus of the acquisition is to build Crown’s footprints in North America with expansion of its consumer portfolio to treat multiple conditions
- Products with indication: PanOxyl is an acne wash, Sarna is an anti-itch lotion, Zeasorb is an anti-fungal and prevention product, Desenex is an anti-fungal for athlete’s foot & Mineral Iceis a pain-relieving gel
Click here to read full press release/ article | Ref: Crown Laboratories | Image: GSK